Today, I woke up to discover that one of my favorite companies developing a hair growth treatment, RiverTown Therapeutics Inc., has launched their website. Site can be viewed here.
One of the new significant announcements shared on the website is the introduction of the Scientific Advisory Board which includes two familiar names: Maria Hordinsky MD and Elaine Fuchs PhD. Both have been prominent at major hair conferences and in the hair growth research field over the past several years.
RiverTown has a few more treatments in development according to its Pipeline page. One of the indications listed is wound healing, very interesting. I like how they have listed their lead candidate drug which you should be familiar with, RT1640; it’s titled as “Hair Regeneration.” yipee. I was also pleased to read positive information about RiverTown’s patent strategy, which should be supportive of its efforts at gaining investment. Send them your best wishes, people.
I bet you’re all eager to go poke around the website now. Here is one interesting quote to leave you with about the hair regeneration treatment RT1640 and its three agents that compose the drug.
“RT1640 is made up of three small molecule drugs that together synergize to act on three distinct pathways in hair biology. One drug promotes the growth and migration of new stem cells, one drug promotes the commitment of the follicular stem cells to become new hair and one protects the dermal papilla from the effects of DHT.”
Happy Friday Everyone.